Critical Reviews in Toxicology: Difference between revisions
wikademia>James w Davis No edit summary |
wikademia>James w Davis No edit summary |
||
| Line 7: | Line 7: | ||
| abbreviation = Crit Rev Toxicol | | abbreviation = Crit Rev Toxicol | ||
| publisher = [[Informa Pharmaceutical Science]] | | publisher = [[Informa Pharmaceutical Science]] | ||
| Frequency = 10 issues per year | | Frequency = 10 issues per year | ||
| History = First published 1971 | | History = First published 1971 | ||
| Line 45: | Line 44: | ||
Subscribers to the electronic edition of '''''Critical Reviews in Toxicology''''' receive access to the online archive, which dates back to 1971, as part of their subscription<ref>>{{cite web |url=http://www.informapharmascience.com/page/brochure |title= Informa Pharmaceutical Science brochure|accessdate=2009-03-10 |format= |work=informapharmascience.com }}</ref>. | Subscribers to the electronic edition of '''''Critical Reviews in Toxicology''''' receive access to the online archive, which dates back to 1971, as part of their subscription<ref>>{{cite web |url=http://www.informapharmascience.com/page/brochure |title= Informa Pharmaceutical Science brochure|accessdate=2009-03-10 |format= |work=informapharmascience.com }}</ref>. | ||
'''''Critical Reviews in Toxicology''''' is owned by [[Informa plc]] (LSE: INF) which is a [[United Kingdom]]-based publisher and conference company, with offices in more than 40 countries and more than 10,000 employees.<ref>>{{cite web |url=http://www.informa.com/contact/office_locations |title= Informa's global locations|accessdate=2006-01-01 |format= |work=informa.com }}</ref> The Company is listed on the [[London Stock Exchange]] and is a constituent of the [[FTSE 250 Index]].<ref>>{{cite web |url=http://www.londonstockexchange.com/en-gb/pricesnews/prices/trigger/indexsector.htm?bsg=true&in=1191732.FTSE |title= FTSE 250|accessdate=2008-11-24 |format= |work=londonstockexchange.com }}</ref> | |||
==References== | ==References== | ||
Revision as of 15:42, 10 March 2009
| Critical Reviews in Toxicology | |
|---|---|
| File:Critical Reviews in Toxicology.jpg | |
| Abbreviated title | Crit Rev Toxicol |
| Discipline | Toxicology, public health |
| Language | English |
| Edited by | Dr Roger O. McClellan, PhD |
| Publication details | |
| Publisher | Informa Pharmaceutical Science ({{{country}}}) |
| Open access | no |
| Impact factor | 5.145 (2007) |
| Indexing | |
| ISSN | 1040-8444 (print) 15476898 (web) |
| Links | |
Critical Reviews in Toxicology is an academic journal that publishes review articles on the mechanisms, responses and assessments of toxins and toxicants.
Core Therapeutic Areas
- toxicology of commodity and specialty chemicals; pharmaceutical agents, consumer products such as macronutrients and food additives, and environmental agents such as ozone and dioxin
- toxicological effects from subtle physiological alterations to overt toxicity manifested in major systems, such as respiratory, gastrointestinal, endocrine, urogenital, musculoskeletal, nervous and immunological systems
- mechanisms of action at all levels of biological organisation, from macromolecules and cells to integrated organisms and populations of laboratory animals and people
Editor-in-Chief
Roger O. McClellan, Ph.D, is the Editor-in-Chief of Critical Reviews in Toxicology[1]. Dr. McClellan currently works as an Advisor in Inhalation Toxicology and Human Health Risk Analysis from his home office in Albuquerque, NM.[2]. He is the author of more than 350 papers and edited 10 books in these fields including the 2 leading texts on inhalation toxicology/respiratory toxicology.
Publication Format
Critical Reviews in Toxicology publishes 10 issues per year in simultaneous print and online editions and is available on a subscription basis. Individual articles can be purchased on a pay-per-view basis. The full text of all articles is offered in PDF and PDF Plus formats. All back-issues of the journal are available online and are hosted on the publisher's website.
Subscribers to the electronic edition of Critical Reviews in Toxicology receive access to the online archive, which dates back to 1971, as part of their subscription[3].
Critical Reviews in Toxicology is owned by Informa plc (LSE: INF) which is a United Kingdom-based publisher and conference company, with offices in more than 40 countries and more than 10,000 employees.[4] The Company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[5]
References
- ↑ >"Editorial Board Members". informapharmascience.com. http://www.informapharmascience.com/page/EditorialAdvisoryBoard?journalCode=txc. Retrieved on 2009-03-10.
- ↑ >"U.S. Environmental Protection Agency". yosemite.epa.gov. http://yosemite.epa.gov/sab/sabpeople.nsf/WebPeople/McClellanRoger%20O.?OpenDocument. Retrieved on 2009-03-10.
- ↑ >"Informa Pharmaceutical Science brochure". informapharmascience.com. http://www.informapharmascience.com/page/brochure. Retrieved on 2009-03-10.
- ↑ >"Informa's global locations". informa.com. http://www.informa.com/contact/office_locations. Retrieved on 2006-01-01.
- ↑ >"FTSE 250". londonstockexchange.com. http://www.londonstockexchange.com/en-gb/pricesnews/prices/trigger/indexsector.htm?bsg=true&in=1191732.FTSE. Retrieved on 2008-11-24.
External links
- Critical Reviews in Toxicology homepage of Critical Reviews in Toxicology
- informapharmascience.com homepage of Informa Pharmaceutical Science, the division of Informa that publishes Critical Reviews in Toxicology
- Informa UK Ltd Informa plc is the leading international provider of specialist information and services for the academic and scientific, professional and commercial business communities.